Loaded wheel running and muscle adaptation in the mouse

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 1 58-1, 2005, Pages

  Konhilas, John P ^a   Widegren, Ulrika ^a   Allen, David L ^a   Paul, Angelika C ^a   Cleary, Allison ^a   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiac adaptation; Cardiomyocyte signaling

Indexed keywords

BETA GALACTOSIDASE; CALCINEURIN; GLYCOGEN SYNTHASE KINASE 3BETA; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE B; PROTEIN P70; S6 KINASE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAGE; CONTROLLED STUDY; EXERCISE; GENETIC ASSOCIATION; HEART HYPERTROPHY; HEART SIZE; MALE; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RUNNING; SKELETAL MUSCLE; SOLEUS MUSCLE; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; TRANSGENE; TREADMILL; WEIGHT BEARING; WEIGHT LIFTING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCINEURIN; DNA-BINDING PROTEINS; EXERTION; GLYCOGEN SYNTHASE KINASE 3; HEART; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MUSCLE, SKELETAL; MYOCARDIUM; MYOGENIC REGULATORY FACTORS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 21644447316     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00085.2005     Document Type: Article

References (60)

1. Allen DL, Harrison BC, Maass A, Bell ML, Byrnes WC, and Leinwand LA. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol 90: 1900-1908, 2001.
2. Antes CL, McKinsev TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, and Olson EN. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 99: 907-912, 2002.
3. Badorff C, Ruetten H, Mueller S, Stahmer M, Gehring D, Jung F, Ihling C, Zeiher AM, and Dimmeler S. Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload. J Clin Invest 109: 373-381, 2002.
4. Balmer J, Davison RC, and Bird SR. Peak power predicts performance power during an outdoor 16.1-km cycling time trial. Med Sci Sports Exerc 32: 1485-1490, 2000.
5. Bentley DJ, McNaughton LR, Thompson D, Vleck VE, and Batterham AM. Peak power output, the lactate threshold, and time trial performance in cyclists. Med Sci Sports Exerc 33: 2077-2081, 2001.
6. Bishop D, Jenkins DG, McEniery M, and Carey MF. Relationship between plasma lactate parameters and muscle characteristics in female cyclists. Med Sci Sports Exerc 32: 1088-1093, 2000.
7. Black BL and Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196, 1998.
8. Booth FW and Thomason DB. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 71: 541-585, 1991.
9. Brooks GA. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 17: 22-34, 1985.
10. Buttrick PM, Kaplan M, Leinwand LA, and Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol 26: 61-67, 1994.
11. Eto Y, Yonekura K, Sonoda M, Arai N, Sata M, Sugiura S, Takenaka K, Gualberto A, Hixon ML, Wagner MW, and Aoyagi T. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 101: 2134-2137, 2000.
12. Fagard RH. Athlete's heart: a meta-analysis of the echocardiographic experience. Int J Sports Med 17, Suppl 3: S140-S144, 1996.
13. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, and Evans WJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 263: 3029-3034, 1990.
14. Fry AC. The role of resistance exercise intensity on muscle fibre adaptations. Sports Med 34: 663-679, 2004.
15. Gruver CL, DeMayo F, Goldstein MA, and Means AR. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133: 376-388, 1993.
16. Guyatt GH and Devereaux PJ. A review of heart failure treatment. Mt Sinai J Med 71: 47-54, 2004.
17. Harrison BC, Bell ML, Allen DL, Byrnes WC, and Leinwand LA. Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. J Appl Physiol 92: 313-322, 2002.
18. Hawley JA and Noakes TD. Peak power output predicts maximal oxygen uptake and performance time in trained cyclists. Eur J Appl Physiol 65: 79-83, 1992.
19. Haykowsky MJ, Dressendorfer R, Taylor D, Mandic S, and Humen D. Resistance training and cardiac hypertrophy: unravelling the training effect. Sports Med 32: 837-849, 2002.
20. Haykowsky MJ, Teo KK, Quinney AH, Humen DP, and Taylor DA. Effects of long-term resistance training on left ventricular morphology. Can J Cardiol 16: 35-38, 2000.
21. Holloszy JO and Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838, 1984.
22. Ishihara A, Roy RR, Ohira Y, Ibata Y, and Edgerton VR. Hypertrophy of rat plantaris muscle fibers after voluntary running with increasing loads. J Appl Physiol 84: 2183-2189, 1998.
23. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, and Robbins J. Ablation of the murine αa-myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 98: 1906-1917, 1996.
24. Kaplan ML, Cheslow Y, Vikstrom K, Malhotra A, Geenen DL, Nakouzi A, Leinwand LA, and Buttrick PM. Cardiac adaptations to chronic exercise in mice. Am J Physiol Heart Circ Physiol 267: H1167-H1173, 1994.
25. Konhilas JP, Maass AH, Luckey SW, Ikeda K, Stauffer BL, Olson EN, and Leinwand LA. Sex modifies exercise and cardiac adaptation in the mouse. Am J Physiol Heart Circ Physiol 287: H2768-H2776, 2004.
26. Kothary R, Clapoff S, Darling S, Perry MD, Moran LA, and Rossant J. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development 105: 707-714, 1989.
27. Kozma SC and Thomas G. Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays 24: 65-71, 2002.
28. 2max and running performance in rats. J Appl Physiol 68: 400-403, 1990.
29. 2 max and cardiac output. Med Sci Sports Exerc 36: 1357-1363, 2004.
30. Lu J, McKinsey TA, Nicol RL, and Olson EN. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97: 4070-4075, 2000.
31. McKinsey TA, Zhang CL, and Olson EN. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci USA 97: 14400-14405, 2000.
32. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, and Izumo S. Phosphoinositide 3-kinase (p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100: 12355-12360, 2003.
33. Mercadier JJ, Lompre AM, Wisnewsky C, Samuel JL, Bercovici J, Swynghedauw B, and Schwartz K. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res 49: 525-532, 1981.
34. Miller JM. Assays for β-galactosidase. In: Molecular Genetics, edited by Miller JM. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1972, p. 352-355.
35. Molkentin JD and Dorn GW II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63: 391-426, 2001.
36. Molkentin JD, Lu JR, Antes CL, Markham B, Richardson J, Robbins J, Grant SR, and Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
37. Molkentin JD and Markham BE. Myocyte-specific enhancer-binding factor (MEF-2) regulates α-cardiac myosin heavy chain gene expression in vitro and in vivo. J Biol Chem 268: 19512-19520, 1993.
38. Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, and Sadoshima J. The Akt-glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem 275: 14466-14475, 2000.
39. Munoz KA, Aannestad A, Tischler ME, and Henriksen EJ. Skeletal muscle protein content and synthesis after voluntary running and subsequent unweighting. Metabolism 43: 994-999, 1994.
40. Nadal-Ginard B and Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest 84: 1693-1700, 1989.
41. Naya FJ, Wu C, Richardson JA, Overbeek P, and Olson EN. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126: 2045-2052, 1999.
42. Neri Serneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, Michelucci A, Colella A, and Galanti G. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 89: 977-982, 2001.
43. Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, and Olson EN. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest 105: 1395-1406, 2000.
44. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, and Sullivan MJ. Exercise and heart failure: a statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Circulation 107: 1210-1225, 2003.
45. Pluim BM, Zwinderman AH, van der Laarse A, and van der Wall EE. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 101: 336-344, 2000.
46. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem 272: 31203-31208, 1997.
47. Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Manunen P, Yang J, Antes CL, Shelton JM, Bassel-Duby R, Olson EN, and Williams RS. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98: 3328-3333, 2001.
48. Schaible TF, Penpargkul S, and Scheuer J. Cardiac responses to exercise training in male and female rats. J Appl Physiol 50: 112-117, 1981.
49. Schaible TF and Scheuer J. Cardiac adaptations to chronic exercise. Prog Cardiovasc Dis 27: 297-324, 1985.
50. Scheinowitz M, Kessler-Icekson G, Freimann S, Zimmermann R, Schaper W, Golomb E, Savion N, and Eldar M. Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression. Growth Horm IGF Res 13: 19-25, 2003.
51. Serneri GG, Modesti PA, Boddi M, Cecioni I, Paniccia R, Coppo M, Galanti G, Simonetti I, Vanni S, Papa L, Bandinelli B, Migliorini A, Modesti A, Maccherini M, Sani G, and Toscane M. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res 85: 57-67, 1999.
52. Sexton WL. Vascular adaptations in rat hindlimb skeletal muscle after voluntary running-wheel exercise. J Appl Physiol 79: 287-296, 1995.
53. Sharma S, Firoozi S, and McKenna WJ. Value of exercise testing in assessing clinical state and prognosis in hypertrophic cardiomyopathy. Cardiol Rev 9: 70-76, 2001.
54. Shioi T, Rang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, and Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548, 2000.
55. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, and Leinwand LA. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 104: 469-481, 1999.
56. Vikstrom KL, Factor SM, and Leinwand LA. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med 2: 556-567, 1996.
57. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, and Molkentin JD. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94: 110-118, 2004.
58. Wilkins BJ and Molkentin JD. Calcineurin and cardiac hypertrophy: Where have we been? Where are we going? J Physiol 541: 1-8, 2002.
59. Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, Simard AR, Michel RN, Bassel-Duby R, Olson EN, and Williams RS. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 19: 1963-1973, 2000.
60. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, and Williams RS. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20: 6414-6423, 2001.